Cargando…

P838: EXOSOME MIRNAS PROFILING IN SERUM AND PROGNOSTIC EVALUATION IN PATIENTS WITH MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales:	Fang, Teng, Sun, Hao, Hao, Mu, Qiu, Lugui, Sun, Xiyue, Zhu, Guoqing, He, Yi, Gong, Lixin, Tang, Peixia, Yu, Zhen, Liu, Lanting, Xie, Shiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431154/ http://dx.doi.org/10.1097/01.HS9.0000970256.67422.8f

Ejemplares similares

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma
por: Fang, Teng, et al.
Publicado: (2023)

P810: A NOVEL INDIRUBIN-3-MONOXIME DERIVATIVES FUNCTION AS DISRUPTORS OF PROTEOSTASIS VIA TARGETING TRIM28 IN MULTIPLE MYELOMA
por: Fang, Teng, et al.
Publicado: (2023)

P818: DNP73 PROMOTES DRUG RESISTANCE AND IMMUNE EVASION IN MULTIPLE MYELOMA BY MODULATING MYC/CD47 AXIS
por: Liu, Lanting, et al.
Publicado: (2023)

Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment
por: Wei, Xiaojing, et al.
Publicado: (2023)

P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA
por: Yu, Zhen, et al.
Publicado: (2023)

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
por: Lv, Junqiang, et al.
Publicado: (2022)

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
por: Hao, Mu, et al.
Publicado: (2011)

838. Oral Vancomycin Prophylaxis Works!
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia
por: Sun, Hao, et al.
Publicado: (2022)

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma
por: Yu, Zhen, et al.
Publicado: (2022)

Vaxman I, Gertz MA. How I approach smoldering multiple myeloma. Blood. 2022;140(8):828-838.
Publicado: (2023)

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
por: Alipoor, Shamila D., et al.
Publicado: (2023)

Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
por: Zhang, Zhi-yao, et al.
Publicado: (2019)

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nuclear Enrichment
por: Xie, Zhenqing, et al.
Publicado: (2021)

Transcriptomic and proteomic profiles of II YOU 838 (Oryza sativa) provide insights into heat stress tolerance in hybrid rice
por: Wang, Yan, et al.
Publicado: (2020)

838 Patient Outcomes and Surgical Complications in Coccidioidal Meningitis: An Institutional Review
por: Moran, Ana, et al.
Publicado: (2014)

838. A Multidisciplinary Approach to the Management of Renal Disease in Patients with HIV
por: Bennani, Yussef, et al.
Publicado: (2021)

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment
por: Liu, Lanting, et al.
Publicado: (2020)

METB-09. GERMLINE PATHOGENIC VARIANTS IN 838 PEDIATRIC BRAIN TUMOR PATIENTS
por: McQuaid, Shelly W, et al.
Publicado: (2023)

Immunotherapy for multiple myeloma: new chances and hope
por: Xu, Jingyu, et al.
Publicado: (2023)

Serum Exosomal miRNAs for Grading Hepatic Fibrosis Due to Schistosomiasis
por: Cai, Pengfei, et al.
Publicado: (2020)

Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2022)

Exploration of Exosomal miRNAs from Serum and Synovial Fluid in Arthritis Patients
por: Xie, Yingying, et al.
Publicado: (2022)

Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration
por: Li, Zhichao, et al.
Publicado: (2022)

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021)

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
por: Li, Fei, et al.
Publicado: (2015)

Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
por: Zang, Meirong, et al.
Publicado: (2020)

Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38
por: Velde, Hedwig M., et al.
Publicado: (2023)

Identification of exosomes and its signature miRNAs of male and female Cynoglossus semilaevis
por: Sun, Zhanpeng, et al.
Publicado: (2017)

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis
por: Hao, Mu, et al.
Publicado: (2016)

Run 836: 26 GeV, ELSA, R1 + R2, Run 838
por: Brand, K, et al.
Publicado: (1977)

Determinants of neonatal deaths in Indonesia: A national survey data analysis of 10,838 newborns
por: Sampurna, Mahendra Tri Arif, et al.
Publicado: (2023)

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014)

Enhanced Recovery After Surgery for Breast Reconstruction: Pooled Meta-Analysis of 10 Observational Studies Involving 1,838 Patients
por: Tan, Ya-Zhen, et al.
Publicado: (2019)

ExosomePurity: tumour purity deconvolution in serum exosomes based on miRNA signatures
por: Wu, Tao, et al.
Publicado: (2023)

Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis
por: Alipoor, Shamila D., et al.
Publicado: (2019)

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases
por: Catelan, Silvia, et al.
Publicado: (2022)

Novel findings from 2,838 Adult Brains on Sex Differences in Gray Matter Brain Volume
por: Lotze, Martin, et al.
Publicado: (2019)

lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_obejq3ca4hodccplh7ko06bm5f